Company Description
Cipla Ltd S/GDR 144A (symbol: CPLFY) is a global pharmaceutical company with a focus on sustainable growth, complex generics, and expanding its portfolio in various markets. Established in 1935, Cipla is known for its strengths in respiratory, anti-retroviral, urology, cardiology, anti-infective, and CNS segments, with manufacturing sites worldwide producing a wide range of products. Cipla is a key player in the pharmaceutical industry, contributing to global health initiatives and making healthcare more accessible and affordable.
Stock Performance
Latest News
SEC Filings
No SEC filings available for Cipla 144 Gdr.